-
NUMBER OF INSIDER BUYING
(Last 12 Months)
3 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$10.10 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$4.19 M
Edgewise Therapeutics, Inc. Insider Transactions
Edgewise Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
KOCH KEVIN
CEO |
Sell | 3,152 @ $18.91 | $59,604 | 14,478 | 05/02/2024 | 05/03/2024 | |
| Sell | 3,682 @ $18.91 | $69,627 | 19,897 | 05/02/2024 | 05/03/2024 | ||
|
MOORE JOHN R
General Counsel |
Sell | 1,956 @ $18.91 | $36,988 | 3,252 | 05/02/2024 | 05/03/2024 | |
| Sell | 2,157 @ $18.91 | $40,789 | 35,230 | 05/02/2024 | 05/03/2024 | ||
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 1,576 @ $18.91 | $29,802 | 7,238 | 05/02/2024 | 05/03/2024 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 1,718 @ $18.91 | $32,487 | 13,422 | 05/02/2024 | 05/03/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 8,029 @ $20.01 | $160,657 | 0 | 02/09/2024 | 02/09/2024 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 4,800 @ $20.04 | $96,209 | 7,020 | 02/09/2024 | 02/09/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 3,813 @ $20.01 | $76,285 | 0 | 02/08/2024 | 02/09/2024 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 4,600 @ $20.01 | $92,049 | 7,020 | 02/08/2024 | 02/09/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 17,993 @ $20.00 | $359,864 | 0 | 02/07/2024 | 02/09/2024 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 600 @ $20.00 | $12,000 | 7,020 | 02/07/2024 | 02/09/2024 | |
| Sell | 90,000 @ $15.78 | $1.42 M | 29,024 | 01/23/2024 | 01/25/2024 | ||
|
Thompson Peter A.
Director, 10 percent owner: |
Buy | 454,545 @ $11.00 | $5.00 M | 14,436,497 | 01/23/2024 | 01/25/2024 | |
|
ORBIMED ADVISORS LLC
Director, 10 percent owner: |
Buy | 454,545 @ $11.00 | $5.00 M | 14,436,497 | 01/23/2024 | 01/25/2024 | |
|
MOORE JOHN R
General Counsel |
Sell | 8,497 @ $10.50 | $89,219 | 0 | 12/27/2023 | 12/28/2023 | |
|
Fox Jonathan C
Director |
Buy | 10,857 @ $9.30 | $100,958 | 10,857 | 12/26/2023 | 12/28/2023 | |
|
Russell Alan J
Director, Chief Scientific Officer |
Sell | 172,585 @ $9.33 | $1.61 M | 3,606 | 12/26/2023 | 12/28/2023 | |
|
Derakhshan Behrad
Chief Business Officer |
Sell | 1,747 @ $8.90 | $15,557 | 7,020 | 05/02/2023 | 05/03/2023 | |
|
MOORE JOHN R
General Counsel |
Sell | 1,897 @ $8.90 | $16,893 | 6,565 | 05/02/2023 | 05/03/2023 |
Edgewise Therapeutics, Inc. Frequently Asked Questions
-
Who is on Edgewise Therapeutics, Inc.'s Insider Roster?
The list of insiders at Edgewise Therapeutics, Inc. includes Russell Alan J, Fox Jonathan C, MOORE JOHN R, ORBIMED ADVISORS LLC, Thompson Peter A., Carruthers R Michael, Derakhshan Behrad, Donovan Joanne M., KOCH KEVIN.
-
How much insider selling is happening at Edgewise Therapeutics, Inc.?
Insiders have sold a total of 325,158 Edgewise Therapeutics, Inc. shares in the last 12 months for a total of 4.19 M sold.
-
Which Edgewise Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Edgewise Therapeutics, Inc. shares in the last 12 months: Russell Alan J ($1.64 M), MOORE JOHN R ($723,012), Carruthers R Michael ($1.46 M), Derakhshan Behrad ($232,745), Donovan Joanne M. ($69,627), KOCH KEVIN ($59,604),
-
How much insider buying is happening at Edgewise Therapeutics, Inc.?
Insiders have purchased a total of 919,947 Edgewise Therapeutics, Inc. shares in the last 12 months for a total of 10.10 M sold.
-
Which Edgewise Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Edgewise Therapeutics, Inc. shares in the last 12 months: Fox Jonathan C ($100,958), ORBIMED ADVISORS LLC ($5.00 M), Thompson Peter A. ($5.00 M),